Fundraising Fox
Artis Biosolutions
1 known investors
Find your way into Artis Biosolutions
723 people in our graph can introduce you to the Artis Biosolutions team.
Sign up to see every warm intro you have to Artis Biosolutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Artis Biosolutions team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Artis BioSolutions develops synthetic DNA and provides integrated manufacturing services for genetic medicine and advanced therapeutic modalities, including cell therapy, gene therapy, mRNA, gene editing, and vaccines. The company serves genetic medicine developers seeking to accelerate clinical development and GMP manufacturing within a single quality framework.
Founders & leadership
BN
Brian NeelBrian Neel has 25 years of experience in life sciences, including leadership roles in diagnostics and therapeutics businesses, with expertise in operations scaling, business transformation, and product development.
MH
Mike Houston
KB
Kate BroderickKate Broderick is an experienced life sciences executive with over 20 years in the industry across startup, biotechnology, CDMO, and public biopharmaceutical settings. She brings expertise in infectious diseases, drug delivery, therapeutics, and gene delivery platforms including non-viral DNA and RNA systems, having led scientific teams and contributed to product development and patent portfolios across multiple geographies.
ES
Eric StierEric Stier has 25 years of experience in legal management roles at healthcare and clinical research organizations, contributing to teams developing diagnostic solutions and clinical capabilities.
PS
Peter StolbaPeter Stolba held senior executive and P&L management roles in biotech and pharmaceutical companies, with background in business development, manufacturing, quality, and drug development across nucleic acids, biologics, and related modalities. He now leads Artis BioSolutions, which provides synthetic DNA manufacturing and integrated services for genetic medicine developers.
Investors · 1
Related companies · 3
Fortis Life SciencesFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Companies working in the same space as Artis Biosolutions.
Frequently asked questions
- What does Artis Biosolutions do?
- Artis BioSolutions develops synthetic DNA and provides integrated manufacturing services for genetic medicine and advanced therapeutic modalities, including cell therapy, gene therapy, mRNA, gene editing, and vaccines. The company serves genetic medicine developers seeking to accelerate clinical development and GMP manufacturing within a single quality framework.
- Who are Artis Biosolutions's investors?
- Artis Biosolutions's investors include Oak HC/FT.